Stock HALO HALOZYME THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts Halozyme Therapeutics, Inc.

Equities

HALO

US40637H1095

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-26 EDT 		5-day change 1st Jan Change
38.57 USD +0.29% Intraday chart for Halozyme Therapeutics, Inc. -0.18% +4.36%
04-25 Halozyme Therapeutics, Inc. Announces the Election of Mahesh Krishnan, M.D. to its Board of Directors CI
04-18 Halozyme Therapeutics Insider Sold Shares Worth $768,390, According to a Recent SEC Filing MT

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bearish

Neutral

Neutral

Resistance 39.73 42.10 43.75
Spread/Res.-2.92%-8.38%-11.84%
Spread/Supp.+2.01%+15.55%+16.17%
Support 37.81 33.38 33.20

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. HALO Stock
  4. Charts Halozyme Therapeutics, Inc.